Lexeo Therapeutics, Inc.
LXEO
Revenue
531.00k
▲531.00k∞%
-Assets
146.94M
▼-26.92M▼-15.49%
3 Months ChangeLiabilities
30.10M
▼-4.44M▼-12.85%
3 Months ChangeFree Cash Flow
-15.05M
▼-15.05M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-30
Form 8-K
ID: 0000950170-24-118569
2024-10-09
Form 8-K
ID: 0000950170-24-113764
2024-08-12
Form 10-Q
ID: 0000950170-24-095057
2024-08-12
Form 8-K
ID: 0000950170-24-095054
2024-07-15
Form 8-K
ID: 0000950170-24-083386
2024-07-08
Form 8-K
ID: 0000950170-24-081942
2024-06-28
Form 8-K
ID: 0000950170-24-078774
2024-05-09
Form 8-K
ID: 0000950170-24-056260
2024-05-09
Form 10-Q
ID: 0000950170-24-056247
2024-04-22
Form 8-K
ID: 0000950170-24-046197